of Coronavirus Under Research Exclusion (SECURE-IBD)
JAPAN IBD COVID-19 TASKFORCE MEMBER


&" % #! # $
Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on April /22/2020.
100%
Overall
Over all
0-9 ye
0-9 ye
Over all
0-9 ye

0 50
4/10/2020 4/15/2020 4/20/2020
0%
10%
20%
30%
40%
2020/4/15 2020/4/22

1. Steroid 2. TNFα6MP/AZA/MTX
0
50
100
150
200
250
COVID-19TNFα
Bude sonide
Oral /p
are nte
Bude sonide
Oral /p
are nte
Bude sonide
Oral /p
are nte
Q5. COVID-19 pandemic A5. (a) SARS-CoV-2 RNA (b) SARS-CoV-2 Angiotensin-converting enzyme 2 SARS-Cov-2 IBD Pandemic IBD 1) IBD 2) 3) 4) COVID-19 3% 10% IBD CT SARS-CoV-2 Personal Protection Equipment 1. Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 5:434-5, 2020 2. Neurath MF: Covid-19 and immunomodulation in IBD. Gut. doi: 10.1136/gutjnl- 2020-321269 3. Marietta Iacucci, Rosanna Cannatelli, Nunzia Labarile, et al. 2. Endoscopy in Inflammatory Bowel Diseases During the COVID-19 Pandemic and Post-Pandemic Period. Lancet Gastroenterol Hepatol. DOI: 10.1016/S2468-1253(20)30119-9 4. Tian Y, Rong L, Mian W, et al. Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
Q6. COVID-19 A6. COVID-19 COVID-19 7 case series study A) 7 5 4 B) 2 ICU COVID-19 118 2019/12/82020/3/20 (a) 0.24%109 92%9 8% (b) 3/20 109 92%) (c) (d) 9 6 COVID-19 SARS-CoV-2 COVID-19
1. Noelle Breslin, Catlin Baptiste, Russell Miller, et al. COVID-19 in pregnancy: early lessons.
Am. J. Gastroenterol https://doi.org/10.1016/j.ajogmf.2020.100111
2. Chen L, Li Q, Zheng D, et al. Clinical Characteristics of Pregnant Women with Covid-19 in
Wuhan, China. N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009226. [Epub ahead of
print]

SARS-CoV-2
®
-®
®
®
®